Gary S. II Stetz Insider Profile
4 Followers
Gary S. II Stetz, Director at Hepion Pharmaceuticals, holds 500.00K shares in Hepion Pharmaceuticals (Ticker: HEPA). Most recently, Gary S. II Stetz Bought 500,000 shares of Hepion Pharmaceuticals on Aug 12, 2026 for an estimated value of $25.00K.
Gary S. II Stetz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Gary S. II Stetz's holdings
Insider Roles
Director
Roles that Gary S. II Stetz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gary S. II Stetz
Gary S. II Stetz's Trading History
List of latest transactions for each holding click on a transaction to see Gary S. II Stetz's performance on stock
You May Also Like
Gary S. II Stetz insider profile FAQ
What is the percentage of profitable transactions made by Gary S. II Stetz?
The percentage of profitable transactions made by Gary S. II Stetz is ―.
What is the average return per transaction made by Gary S. II Stetz?
The average return per transaction made by Gary S. II Stetz is ―.
What stocks does Gary S. II Stetz hold?
Gary S. II Stetz holds: HEPA stocks.
What was Gary S. II Stetz’s latest transaction?
Gary S. II Stetz latest transaction was an Informative Buy of $25.00K.
What was Gary S. II Stetz's most profitable transaction?
Gary S. II Stetz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gary S. II Stetz's role in Hepion Pharmaceuticals?
Gary S. II Stetz's role in Hepion Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.